Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Galera Therapeutics, Inc. Common Stock (GRTX)

Pharmaceutical Preparations

https://www.galeratx.com

Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. Its lead product candidate, GC4419, is a small molecule dismutase mimetic developed for the reduction of severe oral mucositis, or SOM.

45 LIBERTY BLVD., SUITE 230
MALVERN, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/07/2019

Market Cap

3,698,670

Shares Outstanding

54,390,000

Weighted SO

54,392,170

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.9790

Last Div

0.0000

Range

0.051-0.29

Chg

-0.0061

Avg Vol

793114

Mkt Cap

3698670

Exch

NASDAQ

Country

US

Phone

610 725 1500

DCF Diff

0.1396

DCF

0.0004

Div Yield

0.0000

P/S

42.0303

EV Multiple

0.2400

P/FV

-0.0268

Div Yield %

0.0000

P/E

-0.1271

PEG

-0.0030

Payout

0.0000

Current Ratio

5.6265

Quick Ratio

5.6265

Cash Ratio

5.0560

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1255.8475

CCC

-1255.8475

Gross Margin

-1.6818

Op Margin

-310.8864

Pretax Margin

-330.7386

Net Margin

-330.7386

Eff Tax Rate

0.2948

ROA

-1.7765

ROE

0.2195

ROCE

-1.9189

NI/EBT

1.0000

EBT/EBIT

1.0639

EBIT/Rev

-310.8864

Debt Ratio

0.0729

D/E

-0.0087

LT Debt/Cap

-0.0076

Total Debt/Cap

-0.0087

Int Coverage

-9.7987

CF/Debt

-22.8032

Equity Multi

-0.1187

Rec Turnover

0.0000

Pay Turnover

0.2906

Inv Turnover

0.0000

FA Turnover

0.0738

Asset Turnover

0.0054

OCF/Share

-0.5006

FCF/Share

-0.5007

Cash/Share

0.1976

OCF/Sales

-309.3977

FCF/OCF

1.0003

CF Coverage

-22.8032

ST Coverage

-173.4204

CapEx Coverage

-3025.2222

Div&CapEx Cov

-3025.2222

P/BV

-0.0268

P/B

-0.0268

P/S

42.0303

P/E

-0.1271

P/FCF

-0.1358

P/OCF

-0.1358

P/CF

-0.1358

PEG

-0.0030

P/S

42.0303

EV Multiple

0.2400

P/FV

-0.0268

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation